ETF Managers Group’s Tvardi Therapeutics, Inc. Common Stock TVRD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-12,070
| Closed | -$6.57M | – | 691 |
|
|
2020
Q4 | $6.57M | Sell |
12,070
-5,905
| -33% | -$3.22M | 0.14% | 118 |
|
|
2020
Q3 | $8.23M | Sell |
17,975
-7,073
| -28% | -$3.24M | 0.26% | 101 |
|
|
2020
Q2 | $15.4M | Buy |
25,048
+607
| +2% | +$374K | 0.55% | 63 |
|
|
2020
Q1 | $11.6M | Buy |
24,441
+3,589
| +17% | +$1.71M | 0.54% | 65 |
|
|
2019
Q4 | $12.1M | Buy |
20,852
+1,091
| +6% | +$633K | 0.42% | 84 |
|
|
2019
Q3 | $13M | Sell |
19,761
-6,711
| -25% | -$4.42M | 0.47% | 72 |
|
|
2019
Q2 | $20.5M | Buy |
+26,472
| New | +$20.5M | 0.65% | 50 |
|
|
2019
Q1 | – | Sell |
-16,676
| Closed | -$7.62M | – | 589 |
|
|
2018
Q4 | $7.62M | Buy |
+16,676
| New | +$7.62M | 0.36% | 69 |
|
|
2018
Q3 | – | Sell |
-9,861
| Closed | -$75 | – | 622 |
|
|
2018
Q2 | $75 | Buy |
9,861
+486
| +5% | +$4 | 0.01% | 315 |
|
|
2018
Q1 | $3.99M | Buy |
9,375
+5,849
| +166% | +$2.49M | 0.24% | 79 |
|
|
2017
Q4 | $1.63M | Buy |
+3,526
| New | +$1.63M | 0.12% | 102 |
|